Evolutionary Systems Therapy for Personality Pathology

Status Recruiting

Clinical Trial Summary

Evolutionary Systems Therapy is a new form of therapy that has been previously tested in a randomized controlled trial and in a few cases of patients diagnosed with Cluster A personality disorders. The objective of the present study is to investigate the feasibility and preliminary efficacy of Evolutionary Systems Therapy in all forms of personality disorders. The study includes three project actions: (i) a case series on adolescents with personality disorders; (ii) a case series on young adults with personality disorders; (iii) an ecological momentary assessment study to confirm the conceptualization model on all the patients.

Clinical Trial Description

To explore the feasibility and preliminary efficacy of Evolutionary Systems Therapy, the present study includes three actions. In the first action investigators enroll 6 adolescents (16-19 years) with personality disorders, in the second 15 young adults (20-25 years) with personality disorders. All participants receive 6 months of psychotherapy. The two subsamples of patients (adolescents and young adults) are assessed based on the conceptualization model of Evolutionary Systems Therapy which envisages three macro-organizations of personality (consistently with dimensional and hierarchical models such as Hierarchical Taxonomy of Psychopathology): internalizing, externalizing, schizotypal. Investigators plan to recruit patients until the size of the sub-samples is reached (15 young adults divided into 3 groups of 5 patients, each for each of the three interpersonal patterns; 6 adolescents divided into 3 groups of 2 patients, each for each of the three patterns interpersonal). In the third action, an ecological momentary assessment study will investigate the consistency over time between the conceptualization model and the experiences of the young adult patients enrolled: investigators will explore whether the hypothesized conceptualization will be confirmed by collected data on the patients' interpersonal styles. ;

Study Design

Related Conditions & MeSH terms

Personality Disorders

Clinical Trial Details

NCT number	NCT06415812
Study type	Interventional
Source	Tages Onlus
Contact	Alessia Saini
Phone	+39 055679037
Email	alessia.saini@tagesonlus.org
Status	Recruiting
Phase	N/A
Start date	October 2, 2023
Completion date	September 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06367907` - Biological Effects of Schema Therapy	N/A
Recruiting	`NCT05964296` - The Impact of the Use of the MAURISSE Application in People Suffering From an Addiction.	N/A
Completed	`NCT02518906` - Evaluation of AIT Study	N/A
Not yet recruiting	`NCT02126787` - Short-term, Intensive Psychodynamic Group Therapy Versus Cognitive-behavioral Group Therapy in the Day Treatment	N/A
Terminated	`NCT00353379` - Pharmacology of Cognition in Schizotypal Personality Disorder	Phase 4
Active, not recruiting	`NCT05018312` - Modified Collaborative Assessment VS Standard Assessment on Readiness For Psychotherapy Among Patients With Anxiety	N/A
Completed	`NCT04466163` - Strengthening the Healthy Adult Mode: a Case Experimental Study Exploring the Effects of a New Schema Therapy Protocol in an Adult Outpatient Population.	N/A
Not yet recruiting	`NCT03608449` - Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System	N/A
Completed	`NCT05601063` - Ascertaining Diagnosis Classification With Elicited Speech
Completed	`NCT03768674` - Extreme Challenges - Psychopathology & Treatment Experiences Among Severly Selfharming Inpatients in Norway
Completed	`NCT02308462` - Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents	N/A
Terminated	`NCT00400933` - Evaluation of a Six-session Psycho-education Group Program	Phase 1
Completed	`NCT04694482` - The Impact of the COVID-19 (SARS-CoV-2 Disease) on Psychopathology
Recruiting	`NCT05503745` - MICBT for Non-underweight Adults With Eating Disorders	N/A
Completed	`NCT01428349` - Matching Cognitive Remediation to Cognitive Deficits in Substance-Abusing Inmates	N/A
Active, not recruiting	`NCT00378248` - Ullevål PersonalityProject	N/A
Recruiting	`NCT06182787` - Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient
Completed	`NCT02573246` - Neuromodulation Enhanced Cognitive Restructuring: A Proof of Concept Study	N/A
Not yet recruiting	`NCT02397187` - Efficacy of a Structured, Dimension-based, STI in De-compensated Personality-disorder, Hospitalized, Patients	N/A
Completed	`NCT00458094` - Peer Support for Increasing Physical Activity in People With Serious Mental Illnesses	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evolutionary Systems Therapy for Personality Pathology — ESTP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms